MedElevator Войти в исследования
← Поиск публикаций

DOI 10.4103/ijem.ijem_654_18

Медицинская библиотека · Indian journal of endocrinology and metabolism · 2019

Outcomes of Bilateral Adrenalectomy in Cushing's Syndrome.

Nagendra Lakshmi, Bhavani Nisha, Pavithran Praveen V, Kumar Ginil P, Menon Usha V, Menon Arun S, Kumar Lakshmi, Kumar Harish, Nair Vasantha, Abraham Nithya, Narayanan Prem

СтатьяПеревод пока не подготовлен

Аннотация

CONTEXT: The literature on outcomes of bilateral adrenalectomy (BADx) in Cushing's syndrome (CS) is scant.

AIMS: The aim of this study is to analyze the short- and long-term outcomes of patients who underwent BADx and to compare the outcomes among different etiologies of CS.

SETTINGS AND

DESIGN

This is a retrospective analysis of patients who underwent BADx for CS at our center between 2005 and 2018.

MATERIALS AND

METHODS

In all, 33 patients were studied for clinical outcomes, survival rates, and long-term complications.

STATISTICAL ANALYSIS: All analyses were performed with SPSS software (version 21.0).

RESULTS

The mean age at surgery was 39.33 ± 15.67 years. The primary etiology for CS was Cushing's disease (CD) in 42.42%, ectopic source in 36.36%, primary pigmented nodular adrenocortical disease (PPNAD) in 12.12%, and adrenocorticotrophin hormone-independent macronodular adrenal hyperplasia (AIMAH) in 9.09% of patients. The median follow-up time was 72.77 months. Improvement in hypertension and diabetes status after surgery was seen in 78% and 76.19% of patients, respectively. Proximal myopathy improved in 68% of patients. Nelson's syndrome and adrenal crisis were seen in 21.4% of patients each on long-term follow-up. Total mortality after BADx was 33.3%. Mortality in the first 30 days after surgery was seen in five patients (15.15%). Higher cortisol levels at presentation and age more than 40 years were predictors of mortality. Among the Cushing's subtypes, PPNAD had the best prognosis followed by CD. Perioperative Infections were a major cause of mortality.

CONCLUSION

BADx is an effective treatment for CS especially in patients with PPNAD and CD but carries a significant mortality rate too.

Для цитирования: Nagendra Lakshmi, Bhavani Nisha, Pavithran Praveen V, Kumar Ginil P, Menon Usha V, Menon Arun S, Kumar Lakshmi, Kumar Harish, Nair Vasantha, Abraham Nithya, Narayanan Prem. Outcomes of Bilateral Adrenalectomy in Cushing's Syndrome.. Indian journal of endocrinology and metabolism. 2019. DOI: 10.4103/ijem.ijem_654_18.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.